FDA removes black box warning on hormone replacement therapy - UPI.com

Nov. 10 (UPI) -- The Food and Drug Administration announced Monday it would remove the black box warning on hormone replacement therapy for women.

Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary made the announcement at a press conference.

"We are going to stop the fear machine steering women away from this life-changing, even lifesaving, treatment," Makary said at the press conference. "The FDA is taking action to remove the black box warnings from estrogen-related products. This is based on a robust review of the latest scientific evidence."

Makary and other agency officials said the warnings are based on outdated science and have discouraged women from taking hormone therapy.

Related